Budget Reactions: Was pharma sectors wish list fulfilled?

The government has now implemented Alternative Minimum Tax (AMT) for partnership firms as well. This would impact stocks like Cadila and Sun Pharma as they would have to pay 18.5% MAT on book profits earned for the fiscal year. This would increase their tax outgo.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead Travelcafe
moneycontrol.com

Home » News » Budget News

Mar 17, 2012, 12.58 PM | Source: Moneycontrol.com

Budget Reactions: Was pharma sector's wish list fulfilled?

The government has now implemented Alternative Minimum Tax (AMT) for partnership firms as well. This would impact stocks like Cadila and Sun Pharma as they would have to pay 18.5% MAT on book profits earned for the fiscal year. This would increase their tax outgo.

Like this story, share it with millions of investors on M3

Budget Reactions: Was pharma sectors wish list fulfilled?

The government has now implemented Alternative Minimum Tax (AMT) for partnership firms as well. This would impact stocks like Cadila and Sun Pharma as they would have to pay 18.5% MAT on book profits earned for the fiscal year. This would increase their tax outgo.

Post Your Comments

Share Cancel

Nothing substantial was announced for the pharma sector in this Budget. It was a complete non-event for the sector.

The weighted average deduction on R&D continues to be at 200%, nothing new was added to this list. The current irrational structure as far as excise duty on APIs and formulations is concerned, remains.

The government has now implemented Alternative Minimum Tax (AMT) for partnership firms as well. This would impact stocks like Cadila and Sun Pharma as they would have to pay 18.5% MAT on book profits earned for the fiscal year. This would increase their tax outgo.

Also, the Goods and Service Tax (GST) is expected to become operational into play from August 2012, this would increase overall tax rate for the sector.

Hence, there is big gap between what the industry expectated and what was delivered in the Budget.

What the industry had expected

> It expected the government to uniformly exempt all life-saving drugs from GST. This would ensure continued availability of medicines.

> If the benefits granted to units under Tax Free Zone were continued under GST, then tax benefits would prevail and that would act as an incentive for drug manufacturers.

> To ensure proper distribution and availability of drugs across India, 2% CST on interstate transfers was expected to be discontinued. This would also help pharma companies to reduce their transactional costs.

> In order to avoid double taxation under both VAT and Service Tax, all contracts which involve goods and service element were expected to be brought under works contract / benefit of composition scheme.

> To eliminate the current irrational structure, excise duty for APIs was expected to be reduced to 5% from current 10%. Basic customs duty on formulations was expected to be rationalized and reduced to 5% (currently at 10%).

> Excisable goods used for R&D purposes could be exempted from Central Excise Duty besides import of all capital goods, raw materials, consumables.

> A new drug delivery system by extending weighted deduction for R&D activity beyond 2012 was expected, this would give incentives for core R&D activity players as well as incentives for expenditure incurred overseas.

Last year, the pharma industry had expected a number of tax benefits from Budget 2011. But, the government increased MAT to 18.5%, brought units operating in SEZ under MAT and hiked excise duty on medical equipments and some drugs by 1%.

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Budget Reactions: Was pharma sectors wish list fulfilled?

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login